PulseAugur
EN
LIVE 22:37:55
中文(ZH) 礼来28亿美元收购AtaiBeckley，扩充难治性抑郁症治疗管线

Eli Lilly to acquire AtaiBeckley for $2.8B; Uber buys Delivery Hero

By PulseAugur Editorial · [1 sources] ·

Eli Lilly has agreed to acquire AtaiBeckley for approximately $2.8 billion in cash, with potential for an additional $1 billion in milestone payments. This acquisition aims to bolster Eli Lilly's pipeline for treating refractory depression. Separately, Uber is set to acquire Delivery Hero in a deal valued at $14.8 billion, consolidating two major food delivery platforms. Additionally, there are reports that DeepSeek is preparing for an IPO. AI

IMPACT This cluster includes news of DeepSeek preparing for an IPO, which could impact AI sector investment and competition.

RANK_REASON The cluster contains multiple significant business transactions including a major acquisition and a potential IPO. [lever_c_demoted from significant: ic=1 ai=0.4]

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Eli Lilly to acquire AtaiBeckley for $2.8B; Uber buys Delivery Hero

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Research
The cluster contains multiple significant business transactions including a major acquisition and a potential IPO. [lever_c_demoted from significant: ic=1 ai=0.4]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
funding, product, other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Standard
On-topic for AI-industry coverage; kept in the public index.
Story freshness
72 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Lilly acquires AtaiBeckley for $2.8 billion, expanding its pipeline for treatment-resistant depression

    礼来7月16日宣布达成最终协议，将以每股6.75美元现金收购临床阶段生物制药公司AtaiBeckley，交易股权价值约28亿美元。此外，若其两项精神疾病候选疗法达到特定研发及监管里程碑，股东还可获得每股最高2.50美元或有价值权，对应潜在额外股权价值约10亿美元。交易预计于今年第三季度完成，仍需股东及监管批准。（界面）

RELATED ENTITIES

RELATED TOPICS